BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 3187932)

  • 1. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios.
    Naghibi F; Han Y; Dodds WJ; Lawrence CE
    Thromb Haemost; 1988 Jun; 59(3):455-63. PubMed ID: 3187932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100].
    Barbe D; Bauduer F; Tanguy A
    Ann Biol Clin (Paris); 1991; 49(10):507-13. PubMed ID: 1807170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM
    Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three prothrombin time and activated partial thromboplastin time reagent systems on the MLA 700 coagulation analyzer.
    Kritikos VG; Melhem MF
    Clin Lab Sci; 1993; 6(5):302-7. PubMed ID: 10146556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
    McGlasson DL
    Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L; Yan C; Wu X; Nie L
    Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study.
    Guddorf V; Kummerfeld N; Mischke R
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is duplicate testing for prothrombin time and activated partial thromboplastin time necessary?
    Keshgegian AA; Mann JM; Cooper JH
    Arch Pathol Lab Med; 1986 Jun; 110(6):520-2. PubMed ID: 3754725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
    Webster PS; Oleson FB; Paterson DL; Arkin CF; Mangili A; Craven DE; Adcock DM; Lindfield KC; Knapp AG; Martone WJ
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):32-8. PubMed ID: 18180613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simultaneous evaluation of three multiparametric coagulation instruments: BFA, HEMOLAB and STA.
    Pernod G; Bouabana B; Desrousseau B; Mossuz P; Drevait JM; Maljournal B; Rouhan D; Kolodié L; Polack B
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):409-18. PubMed ID: 7753611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.